Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 17;22(2):889.
doi: 10.3390/ijms22020889.

A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient

Ava Kwong  1   2   3 , Cecilia Y S Ho  4 , Vivian Y Shin  1 , Chun Hang Au  4 , Tsun Leung Chan  3   4 , Edmond S K Ma  3   4
Affiliations
Case Reports

A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient

Ava Kwong et al. Int J Mol Sci. .

Abstract

The germline carrier of the BRCA1 pathogenic mutation has been well proven to confer an increased risk of breast and ovarian cancer. Despite BRCA1 biallelic pathogenic mutations being extremely rare, they have been reported to be embryonically lethal or to cause Fanconi anemia (FA). Here we describe a patient who was a 48-year-old female identified with biallelic pathogenic mutations of the BRCA1 gene, with no or very subtle FA-features. She was diagnosed with ovarian cancer and breast cancer at the ages of 43 and 44 and had a strong family history of breast and gynecological cancers.

Keywords: Chinese; Fanconi anemia; compound heterozygous mutations; hereditary breast cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
(A) Electropherogram showing that deletion of exon 22 on BRCA1 c.5406+7A>G splicing. Deletion was detected by cDNA sequencing, (B) Gel electropherogram showing that deletion of 74bp by RT-PCR on BRCA1 c.5406+7A>G. Lane M: 50-bp DNA ladder marker; lane C: Normal human cDNA control; lane S: Proband’s cDNA. HtNM: Heteroduplexes of wild-type and mutant; HmW: Homoduplexes of wild-type; HmM: Homoduplexes of mutant.
Figure 2
Figure 2
Pedigree of proband’s family. formula image: carrier of BRCA1: c.5406+7A>G; r.5333_5406del74; p.Asp1778Glyfs*27 mutations; formula image: carrier of BRCA1: c.4065_4068delTCAA; p.Asn1355Lysfs*10.
Figure 3
Figure 3
(A,B) Pedigree of the 2 families in our Hereditary Breast Cancer Family Registry with BRCA1: c.5406+7A>G; r.5333_5406del74; p.Asp1778Glyfs*27 mutations. formula image: carrier of BRCA1: c.5406+7A>G; r.5333_5406del74; p.Asp1778Glyfs*27 mutations.
See this image and copyright information in PMC

References

    1. Goldgar D., Easton D.F., Deffenbaugh A.M., Monteiro A.N.A., Tavtigian S.V., Couch F.J. Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to BRCA1 and BRCA2. Am. J. Hum. Genet. 2004;75:535–544. doi: 10.1086/424388. - DOI - PMC - PubMed
    1. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 1996;12:191–194. doi: 10.1038/ng0296-191. - DOI - PubMed
    1. Liu C.-Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 1996;10:1835–1843. doi: 10.1101/gad.10.14.1835. - DOI - PubMed
    1. Hohenstein P., Kielman M.F., Breukel C., Bennett L.M., Wiseman R., Krimpenfort P., Cornelisse C., Van Ommen G.-J., Devilee P., Fodde R. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. Oncogene. 2001;20:2544–2550. doi: 10.1038/sj.onc.1204363. - DOI - PubMed
    1. Evers B., Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: Past lessons, current understanding and future prospects. Oncogene. 2006;25:5885–5897. doi: 10.1038/sj.onc.1209871. - DOI - PubMed

Publication types

LinkOut - more resources